Myelodysplastic Syndromes (MDS)

Supportive Care Management - 2024 Los Angeles Patient and Family Conference

Topic(s)

Managing Your Treatment

Presenter(s)

Erin Kopp, DNP

Erin Kopp explains strategies for dealing with pain and other issues for patients with bone marrow failure diseases in this session from the 2024 Los Angeles Patient and Family Conference.

A Patient Story with Ruth Cuadra - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Aplastic Anemia

Myelodysplastic Syndromes (MDS)

Patient Ruth Cuadra describes her journey facing the challenges of aplastic anemia and MDS in this recording from the 2024 Los Angeles Patient and Family Conference.

Inherited Bone Marrow Failure Syndromes - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Aplastic Anemia

Myelodysplastic Syndromes (MDS)

Presenter(s)

Paibel Aguayo-Hiraldo, MD

Dr. Paibel Aguayo-Hiraldo, MD, anticipates your questions about inherited bone marrow failure syndromes in this recording from the 2024 Los Angeles Patient and Family Conference.

Cardiovascular Concerns after HCT from the 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Bone Marrow Transplant

Presenter(s)

June-Wha Rhee, MD

Dr. June-Wha Rhee describes the potential for cardiovascular complications after HCT, or hematopoietic stem cell transplantation, in this session from the 2024 Los Angeles Patient and Family Conference.

Transplant for Aplastic Anemia and MDS - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Bone Marrow Transplant

Aplastic Anemia

Myelodysplastic Syndromes (MDS)

Presenter(s)

Ryotaro Nakamura, MD

Dr. Ryotaro Nakamura explains the entire process for bone marrow transplantation in this recorded session from the 2024 Los Angeles Patient and Family Conference. Learn the potential ways transplants can help patients with aplastic anemia or MDS.

Advances in Treating Lower Risk MDS - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Myelodysplastic Syndromes (MDS)

Presenter(s)

Brian Ball, MD

Learn about recent research and clinical advances for treating Low-Risk MDS, or Myelodysplastic Syndromes in this session from Dr. Brain Ball.

Emerging Therapies in High-Risk MDS - 2024 Los Angeles Patient and Family Conference

Thumbnail for video Watch Now

Topic(s)

Myelodysplastic Syndromes (MDS)

Presenter(s)

Zahra Pakbaz, MD

Discover the most recent treatments and therapies available for High-Risk MDS, or Myelodysplastic Syndromes, in this recorded session featuring Dr. Zahra Pakbaz.

SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes

Read more about SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes

Higher-risk myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLASS-tik SIN-dromez) A group of disorders wh

Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies

Read more about Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies

Introduction: In patients with myelodysplastic syndromes myelodysplastic syndromes: (my-eh-lo-diss-PLAS

Athletic Service Member Conquers Aplastic Anemia and MDS with Transplant

Subscribe to Myelodysplastic Syndromes (MDS)

NFL Player Teams Up with AAMDSIF

Myelodysplastic Syndromes (MDS)

Supportive Care Management - 2024 Los Angeles Patient and Family Conference

A Patient Story with Ruth Cuadra - 2024 Los Angeles Patient and Family Conference

Inherited Bone Marrow Failure Syndromes - 2024 Los Angeles Patient and Family Conference

Cardiovascular Concerns after HCT from the 2024 Los Angeles Patient and Family Conference

Transplant for Aplastic Anemia and MDS - 2024 Los Angeles Patient and Family Conference

Advances in Treating Lower Risk MDS - 2024 Los Angeles Patient and Family Conference

Emerging Therapies in High-Risk MDS - 2024 Los Angeles Patient and Family Conference

SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes

Luspatercept in low-risk myelodysplastic syndromes: a paradigm shift in treatment strategies

Athletic Service Member Conquers Aplastic Anemia and MDS with Transplant

Website Feedback